Article
Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds.
Journal of pediatric endocrinology & metabolism : JPEM - 1 Jul 2015
Zhang Miaoying, Chen Xiuli, Shen Shuixian, Li Tang, Chen Linqi, Hu Min, Cao Lingfeng, Cheng Ruoqian, Zhao Zhuhui, Luo Feihong
Abstract excerpt
OBJECTIVE: The pathogenic base of neonatal diabetes mellitus (NDM) is highly heterogeneous. Sulfonylurea (SU) has been successfully applied in majority of NDM patients with KATP channel mutations; however, its rationality and effectiveness among patients with NDM stemmed from other genetic mutations have not been established. The objective of the present study was to investigate the effectiveness of SU therapy in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
